Percutaneous ethanol injection is an acceptable bridging therapy to hepatocellular carcinoma prior to liver transplantation

[1]  J. Bruix,et al.  BCLC strategy for prognosis prediction and treatment recommendation Barcelona Clinic Liver Cancer (BCLC) staging system. The 2022 update. , 2021, Journal of hepatology.

[2]  H. Tseng,et al.  Diagnostic Criteria and LI‐RADS for Hepatocellular Carcinoma , 2021, Clinical liver disease.

[3]  J. Roberts,et al.  A novel waitlist dropout score for hepatocellular carcinoma - identifying a threshold that predicts worse post-transplant survival. , 2020, Journal of hepatology.

[4]  M. Chedid,et al.  MELD EXCEPTION POINTS PROVIDE AN ENOURMOUS ADVANTAGE FOR RECEIVING A LIVER TRANSPLANT IN BRAZIL. , 2020, Arquivos de gastroenterologia.

[5]  Pei-Hong Wu,et al.  Radiofrequency Ablation Following Downstaging of Hepatocellular Carcinoma by Using Transarterial Chemoembolization: Long-term Outcomes. , 2019, Radiology.

[6]  Zhen Wang,et al.  Therapies for patients with hepatocellular carcinoma awaiting liver transplantation: A systematic review and meta‐analysis , 2018, Hepatology.

[7]  M. Abecassis,et al.  AASLD guidelines for the treatment of hepatocellular carcinoma , 2018, Hepatology.

[8]  M. Chedid.  Nonalcoholic Steatohepatitis: The Second Leading Indication for Liver Transplantation in the USA , 2017, Digestive Diseases and Sciences.

[9]  P. Puri,et al.  Liver Transplantation for Nonalcoholic Steatohepatitis in the US: Temporal Trends and Outcomes , 2017, Digestive Diseases and Sciences.

[10]  J. Trotter.  Liver transplantation around the world , 2017, Current opinion in organ transplantation.

[11]  C. Couto,et al.  Liver Transplantation in Brazil , 2016, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[12]  A. C. Maciel,et al.  Transarterial Embolization and Percutaneous Ethanol Injection as an Effective Bridge Therapy before Liver Transplantation for Hepatitis C-Related Hepatocellular Carcinoma , 2015, Gastroenterology research and practice.

[13]  J. Hiatt,et al.  Complete pathologic response to pretransplant locoregional therapy for hepatocellular carcinoma defines cancer cure after liver transplantation: analysis of 501 consecutively treated patients. , 2015, Annals of surgery.

[14]  R. Hirose,et al.  Downstaging of hepatocellular cancer before liver transplant: Long‐term outcome compared to tumors within Milan criteria , 2015, Hepatology.

[15]  A. Israni,et al.  Delayed hepatocellular carcinoma model for end‐stage liver disease exception score improves disparity in access to liver transplant in the United States , 2015, Hepatology.

[16]  W. Weichert,et al.  Impact of neoadjuvant transarterial chemoembolization on tumor recurrence and patient survival after liver transplantation for hepatocellular carcinoma: a retrospective analysis , 2012, Clinical transplantation.

[17]  R. Vilana,et al.  Percutaneous ethanol injection before liver transplantation in the hepatocellular carcinoma. , 2009, Annals of hepatology.

[18]  L. Bolondi,et al.  Liver Transplantation for Hepatocellular Carcinoma: Results of Down‐Staging in Patients Initially Outside the Milan Selection Criteria , 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[19]  W. Chapman,et al.  Outcomes of Neoadjuvant Transarterial Chemoembolization to Downstage Hepatocellular Carcinoma Before Liver Transplantation , 2008, Annals of surgery.

[20]  Samantha C Huo,et al.  Validation of the HCC‐MELD for dropout probability in patients with small hepatocellular carcinoma undergoing locoregional therapy , 2008, Clinical transplantation.

[21]  Eva Pagano,et al.  Radiofrequency ablation versus ethanol injection for early hepatocellular carcinoma: A randomized controlled trial , 2008, Scandinavian journal of gastroenterology.

[22]  P. Angeli,et al.  Intention‐to‐Treat Analysis of Liver Transplantation in Selected, Aggressively Treated HCC Patients Exceeding the Milan Criteria , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[23]  M. Pompili,et al.  Percutaneous ablation procedures in cirrhotic patients with hepatocellular carcinoma submitted to liver transplantation: Assessment of efficacy at explant analysis and of safety for tumor recurrence , 2005, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[24]  I. Abdulkader,et al.  Prospective histopathological analysis of hepatocellular carcinoma treated with percutaneous ethanol injection in patients on the waiting list for liver transplantation. , 2005, Transplantation proceedings.

[25]  N. Demartines,et al.  Classification of Surgical Complications: A New Proposal With Evaluation in a Cohort of 6336 Patients and Results of a Survey , 2004, Annals of Surgery.

[26]  A. Chedid,et al.  Spontaneous rupture of hepatocellular carcinoma with haemoperitoneum: a rare condition in Western countries. , 2001, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[27]  P. Kamath,et al.  A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts , 2000, Hepatology.

[28]  M. Kallas,et al.  Liver transplantation in Brazil. , 1998, Transplantation proceedings.

[29]  H. Fukuda,et al.  Natural course of small hepatocellular carcinoma with underlying cirrhosis. A study of 30 patients. , 1998, Hepato-gastroenterology.

[30]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[31]  Patrick M M Bossuyt,et al.  Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report. , 2012, The Lancet. Oncology.

[32]  ndrea,et al.  Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. , 1996, The New England journal of medicine.

[33]  D. Woodfield.  Hepatocellular carcinoma. , 1986, The New Zealand medical journal.

[34]  J. Higginson,et al.  International Agency for Research on Cancer. , 1968, WHO chronicle.